Core Laboratories Inc. (NYSE:CLB) Q2 2024 Earnings Call July 25, 2024 8:30 AM ET Larry Bruno Company Participants Conference Call Participants Operator Thanks, Chris. Good morning in the Americas. Good afternoon in Europe, Africa and the Middle East and good evening in Asia-Pacific. WeÂ'd like to welcome all of our shareholders, analysts and most importantly, our employees to Core Laboratories second quarter 2024 earnings call. This morning, I am joined by Chris Hill, CoreÂ's Chief Financial Officer; and Gw ...

This quarterly report represents an earnings surprise of 4.76%. A quarter ago, it was expected that this energy services company would post earnings of $0.16 per share when it actually produced earnings of $0.19, delivering a surprise of 18.75%. Core Laboratories, which belongs to the Zacks Oil and Gas - Field Services industry, posted revenues of $130.58 million for the quarter ended June 2024, missing the Zacks Consensus Estimate by 1.33%. This compares to year-ago revenues of $127.88 million. The company ...

| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | |-----------------------------------------------------------------|-------|------------------------|-------|-------------|-------------------------|-------|------------------------------|---------------------|--------------------------------| | ASSETS: \nCash and cash equivalents | $ | June 30, 2024 \n17,695 | $ | (Unaudited) | March 31, 2024 \n14,913 | $ | December 31, 2023 \n15,120 | vs. Q1-24 \n18.7% | % Variance \nvs. Q4-23 \n17.0% | | | | | ...

Core Laboratories Inc. (CLB) is set to release second-quarter earnings on Jul 24, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter is a profit of 22 cents per share on revenues of $133.34 million. Highlights of Q1 Earnings The Zacks Consensus Estimate for second-quarter 2024 earnings has witnessed an upward and a downward movement in the past 30 days. The estimated figure indicates a 4.76% year-over-year increase. The Zacks Consensus Estimate for revenues indicates an incr ...

Estimate Revisions Trend The consensus EPS estimate for the quarter has been revised 3.13% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period. Estimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ES ...

As of Mar 31, 2024, Core Laboratories had cash and cash equivalents of $14.9 million and long-term debt of $160.4 million. The company's debt-to-capitalization was 40.3%. A month has gone by since the last earnings report for Core Laboratories (CLB) . Shares have added about 6.2% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Core Laboratories due for a pullback? Before we dive into how investors and analysts have reacted ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________________ to ______________ Commission File Number: 001-41695 6316 Windfern Road Houston, TX 77040 (Address of principal executive offices) (Zip Code) Securities ...

These types of forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to materially differ from our forward-looking statements. These risks and uncertainties are discussed in our most recent annual report on Form 10-K as well as other reports and registration statements filed by us with the SEC. A reconciliation to the most directly comparable GAAP financial measures is included in the press release announcing our first quarter results. Those non-GAAP m ...

Core Laboratories (CLB) reported first-quarter 2024 adjusted earnings of 19 cents per share, which beat the Zacks Consensus Estimate of 16 cents. This can be attributed to better-than-expected performance from the Reservoir Description segment. The bottom line was in line with the year-ago quarter’s reported figure.However, this oilfield service provider’s operating revenues of $129.6 million beat the Zacks Consensus Estimate of $124 million by 4.5%. The top line increased 0.9% from the year-ago quarter’s l ...

Exhibit 99.1 FOR IMMEDIATE RELEASE CORE LAB REPORTS FIRST QUARTER 2024 RESULTS: • FIRST QUARTER REVENUE OF $129.6 MILLION, UP MODESTLY SEQUENTIALLY AND YEAROVER-YEAR • FIRST QUARTER OPERATING INCOME OF $8.6 MILLION; EX-ITEMS, $14.9 MILLION, FLAT SEQUENTIALLY, UP 3% YEAR-OVER-YEAR • FIRST QUARTER OPERATING MARGINS, EX-ITEMS, OF 12% • FIRST QUARTER GAAP EPS OF $0.07; EX-ITEMS, $0.19, FLAT SEQUENTIALLY AND YEAR-OVERYEAR • FIRST QUARTER FREE CASH FLOW OF $2.5 MILLION • COMPANY ANNOUNCES Q2 2024 QUARTERLY DIVIDE ...